{
    "organizations": [],
    "uuid": "77d5cfc18b425086803c84ad8b2d03840397028c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clarus-lifesciences-ii-lp-reports/brief-clarus-lifesciences-ii-lp-reports-a-6-92-pct-stake-in-catabasis-pharmaceuticals-as-of-march-22-idUSFWN1RH0L5",
    "ord_in_thread": 0,
    "title": "BRIEF-Clarus Lifesciences II Lp Reports A 6.92 Pct Stake In Catabasis Pharmaceuticals As Of March 22",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Catabasis Pharmaceuticals Inc:\n* CLARUS LIFESCIENCES II LP REPORTS A 6.92 PCT STAKE IN CATABASIS PHARMACEUTICALS INC AS OF MARCH 22 - SEC FILING\n* CLARUS LIFESCIENCES II LP PREVIOUSLY REPORTED A 11.92 PERCENT STAKE IN CATABASIS PHARMACEUTICALS AS OF OCT. 31, 2017 Source text for Eikon: ( bit.ly/2JjI0wt ) Further company coverage:\n ",
    "published": "2018-04-05T04:53:00.000+03:00",
    "crawled": "2018-04-05T00:13:45.022+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "catabasis",
        "pharmaceutical",
        "inc",
        "clarus",
        "lifesciences",
        "ii",
        "lp",
        "report",
        "pct",
        "stake",
        "catabasis",
        "pharmaceutical",
        "inc",
        "march",
        "sec",
        "filing",
        "clarus",
        "lifesciences",
        "ii",
        "lp",
        "previously",
        "reported",
        "percent",
        "stake",
        "catabasis",
        "pharmaceutical",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}